PMID: 6973687Jan 1, 1981Paper

Low- and high-risk non-T and non-B and T-cell acute lymphoid leukemia (ALL) in childhood: different duration of remission and survival

Medical and Pediatric Oncology
P ImbachH P Wagner

Abstract

In a prospective, nonrandomized trial clinical (initial WBC and chest film) and immunological (surface immunoglobulin and rosetting with pretreated sheep red blood cells) criteria were used to stratify 69 children with previously untreated acute lymphoid leukemia (ALL). Forty of 61 evaluable patients had low-risk ALL (initial WBC less than or equal to 20,000/mm3, no mediastinal mass) and were treated less intensively. Twenty-one of 61 patients had high-risk ALL (initial WBC greater than 20,000/mm3 and/or mediastinal mass) and were treated more intensively. Of the high-risk patients 15 had non-T non-B and 6 T ALL. Sixty of 61 patients went into complete remission. After a median observation period of 27 months, 32 of 40 low-risk, 7 of 14 high-risk non-T non-B, and none of 6 high-risk T ALL patients were in continuous first remission. Thirty-six of 40 low-risk, 9 of 15 high-risk non-T non-B, and none of 6 T ALL patients were alive. Despite more intensive treatment, the duration of remission and the survival were significantly shorter in the high-risk than in the low-risk patients. Among the high-risk ALL, non-T non-B ALL did better than T ALL.

References

Mar 2, 1978·The New England Journal of Medicine·R B EllisM F Greaves
Apr 20, 1978·The New England Journal of Medicine·L B VoglerM D Cooper
Jan 1, 1979·American Journal of Hematology·R B RaneyH W Hann
Aug 1, 1978·Cancer·J C Brouet, M Seligmann
Jan 1, 1979·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·A V HoffbrandG Janossy
Apr 17, 1975·The New England Journal of Medicine·L Sen, L Borella
Jan 1, 1980·Medical and Pediatric Oncology·W M CristG Merijanian
May 1, 1980·British Journal of Haematology·J V Simone
May 1, 1980·Pediatric Clinics of North America·D R Miller
Jan 1, 1980·Medical and Pediatric Oncology·A T MeadowsD Hammond

❮ Previous
Next ❯

Citations

Nov 1, 1983·Human Immunology·V E Von FliednerM Wyss
Jul 24, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·K C BholA R Ahmed
Feb 6, 2002·Springer Seminars in Immunopathology·L RauovaY Shoenfeld
Sep 26, 2006·Journal of Neurology·Martin Stangel, Refik Pul
Sep 20, 2008·Journal of Neurology·Hans-Peter Hartung
Sep 20, 2008·Journal of Neurology·Richard Hughes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

© 2021 Meta ULC. All rights reserved